Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Cannabis Law Report

JULY 6, 2021

David Bradley, Chief Executive of South London and Maudsley NHS Foundation Trust, said, “We believe this collaboration could accelerate much-needed research that will translate into evidence-based and direct patient care for people who use our services. London, UK – 5 July 2021.

Research and Development 98

Research and Development Clinical Trials Therapy Patients 98

Cannabis Law Report

DECEMBER 14, 2019

Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. million in the Melbourne cannabis firm in 2018. Give me my free report!

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 29, 2019

Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). Lack of clinical trials is a major reason why doctors are cautious about the drug.

Medicine 59

Medicine Clinical Trials Treatment Access 59

Puff Puff Post

OCTOBER 3, 2019

Montefiore Medical Center in New York and GW Pharmaceuticals are examining the effects of a cannabis compound when administered to children on the autism spectrum. The cannabis compound referred to as cannabidivarin (CBDV) is a non-psychoactive chemical that does not cause a “high” when consumed.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Healer

MARCH 26, 2021

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said the children’s experiences on medicinal cannabis in the should be taken into account as evidence of how well the drug works. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

The Cannigma

MARCH 7, 2022

Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. Licensed wholesalers will be able to import larger quantities of cannabis-based products, and hold supplies for future use by patients with prescriptions, according to a government release.

Medicine 59

Medicine Research and Development Clinical Trials Patients 59

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105

Law Therapy Clinical Trials Research and Development 105

FloridaMarijuana.net

AUGUST 15, 2018

Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the symptoms of PTSD.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

AUGUST 19, 2021

Legal cannabis consumption and it isn’t even legal yet. If and when cannabis is actually properly regulated we’re sure the UK can be a world beater!! Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora is a drug-development company founded in 2018 in Copenhagen, Denmark. Lophora – www.lophora.com.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

The Cannigma

JUNE 23, 2022

CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. The CBGA is made within the trichome of the cannabis plant and is converted by specific enzymes into other cannabinoids. Common cannabinoids in cannabis. What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

Canna Care Docs

DECEMBER 11, 2018

For many who were young in the 1960s and 70s, cannabis was something seen at parties, possibly experimented with, but for the most part set aside. But what explains this turnaround, and what do seniors need to be aware of when it comes to medical cannabis? Here, too, cannabis has been shown to have a distinct effect.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. Medicinal cannabis products have been available since 2018. million patients currently accessing cannabis through the illicit market.

Access 52

Access CBD Research and Development Medicine 52

MedicalJane

JUNE 29, 2018

None of the approved drugs contain, or are derived from, the whole cannabis plant. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. FDA Grants Approval of Epidiolex.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. This disconnect is commonly referred to as the placebo effect.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. After Approval, It’s Off to Treatment Clinics.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

MARCH 1, 2019

Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. Whilst legalised nearly four months ago, so far virtually no-one in the UK has actually been able to obtain a prescription for medicinal cannabis.

Medicine 45

Medicine Clinical Trials Patients Treatment 45

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. The Epidiolex FDA approval is big news for the medical marijuana industry and could help improve perceptions about medical cannabis all over the country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

AUGUST 4, 2019

Founded in 2018, ATAI finances clinical trials for drugs that incorporate psychedelic compounds that could potentially be used to treat mental health disorders. Echoes of cannabis. However, again like cannabis, there is a growing body of evidence that the chemicals could be used to treat various mental health problems.

Medicine 40

Medicine Therapy Clinical Trials Treatment 40

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome patient pool and forecasted trend for each seven major countries. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken. deletion syndrome is often underdiagnosed and misdiagnosed, as the symptoms vary from patient to patient.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

LifeCannMD

AUGUST 23, 2021

percent of the patients. CBD’s benefit is its ability to help patients remain sleeping – as opposed to just helping in the initial stages of sleep. All of which are available in our online store and our Miami Medical Marijuana Clinic. Most clinical trials have involved doses between 25 to 1,500 mg.

CBD 52

CBD Sleep Clinical Trials Cannabinoids 52

CannaMD

NOVEMBER 6, 2019

Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. Using Cannabis to Quit Opioids. In the fall of 2018, scientists at the San Francisco Veterans Affairs Medical Center released findings from a survey on the subject of marijuana versus opioids.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Medical Cannabis Seedbank

FEBRUARY 26, 2018

Cannabis and cancer, quite a popular topic, however, many people have to face the reality of either; dealing with cancer themselves or having an immediate family member or friend having to fight the deadly disease. The alternative treatment that we will focus on in this post is the use of medical cannabis and its healing qualities.

Treatment 63

Treatment Patients Clinical Trials THC 63

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. How Do CBD Drug Interactions Occur? topiramate.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JULY 15, 2019

PUBLISHER: CANNABIS LAW REPORT. July 18 marks the first anniversary of the Portuguese medical cannabis law. The major merit of Decree Law 8/2019 was to provide a clear distinction between cannabis-based medicinal products, cannabis-based preparations and cannabis-based substances (dried flower and oils).

Medicine 40

Medicine Clinical Trials Patients Access 40

Puff Puff Post

OCTOBER 3, 2019

Montefiore Medical Center in New York and GW Pharmaceuticals are examining the effects of a cannabis compound when administered to children on the autism spectrum. The cannabis compound referred to as cannabidivarin (CBDV) is a non-psychoactive chemical that does not cause a “high” when consumed.

Research and Development 40

Research and Development Epilepsy Clinical Trials Treatment 40

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55